Sign in / Join Now
ETFs & Funds
experiencing heavy volume still. In my opinion it's still the most undervalued stem-cell company in the sector.
I think your right josh !!
Add a reply...
Latest StockTalks »
people get ATHX breaking news and analysis by email alert.
Get email alerts on ATHX »
Get latest price
From other sites
Athersys Subsidiary And Leading Animal Health Company Enter Into Research And Option Agreement For Cell Therapy
at TheStreet (Wed, 6:00AM)
Athersys To Present At Stifel 2016 Healthcare Conference In New York
at TheStreet (Nov 3, 2016)
Athersys To Host Third Quarter Financial Results Call
at TheStreet (Oct 11, 2016)
Athersys (ATHX) Shows Strength: Stock Moves 5.1% Higher
at Zacks.com (Sep 29, 2016)
Athersys’s Therapy Prospect Boosted by FDA (ATHX)
at Investopedia (Sep 29, 2016)